EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,296 | -82.0% | 20,640 | -58.5% | 0.00% | – |
| Q2 2023 | $35,003 | -75.9% | 49,720 | -69.4% | 0.00% | – |
| Q1 2023 | $145,539 | -8.4% | 162,269 | +20.5% | 0.00% | – |
| Q4 2022 | $158,842 | -84.7% | 134,612 | -2.4% | 0.00% | – |
| Q3 2022 | $1,038,000 | +40.5% | 137,927 | +17.6% | 0.00% | – |
| Q2 2022 | $739,000 | -26.5% | 117,266 | -3.2% | 0.00% | – |
| Q1 2022 | $1,005,000 | +53.2% | 121,110 | -4.3% | 0.00% | – |
| Q4 2021 | $656,000 | -21.2% | 126,597 | +1.4% | 0.00% | – |
| Q3 2021 | $833,000 | -15.3% | 124,856 | +8.1% | 0.00% | – |
| Q2 2021 | $984,000 | +7.1% | 115,483 | +11.2% | 0.00% | – |
| Q1 2021 | $919,000 | -28.4% | 103,848 | -0.6% | 0.00% | – |
| Q4 2020 | $1,284,000 | +67.2% | 104,498 | +10.7% | 0.00% | – |
| Q3 2020 | $768,000 | -12.6% | 94,373 | +3.0% | 0.00% | – |
| Q2 2020 | $879,000 | +68.4% | 91,626 | +19.3% | 0.00% | – |
| Q1 2020 | $522,000 | -53.9% | 76,783 | +0.9% | 0.00% | – |
| Q4 2019 | $1,133,000 | +48.9% | 76,085 | +2.6% | 0.00% | – |
| Q3 2019 | $761,000 | -1.2% | 74,159 | +2.0% | 0.00% | – |
| Q2 2019 | $770,000 | +134.0% | 72,712 | +209.4% | 0.00% | – |
| Q1 2019 | $329,000 | +64.5% | 23,504 | +19.3% | 0.00% | – |
| Q4 2018 | $200,000 | -16.3% | 19,697 | -1.1% | 0.00% | – |
| Q3 2018 | $239,000 | -4.0% | 19,919 | -2.4% | 0.00% | – |
| Q2 2018 | $249,000 | +69.4% | 20,412 | +36.8% | 0.00% | – |
| Q1 2018 | $147,000 | -26.1% | 14,920 | +4.7% | 0.00% | – |
| Q4 2017 | $199,000 | +24.4% | 14,257 | -2.1% | 0.00% | – |
| Q3 2017 | $160,000 | +39.1% | 14,567 | 0.0% | 0.00% | – |
| Q2 2017 | $115,000 | -26.8% | 14,567 | +6.4% | 0.00% | – |
| Q1 2017 | $157,000 | +3.3% | 13,696 | +4.7% | 0.00% | – |
| Q4 2016 | $152,000 | -7.9% | 13,082 | +6.2% | 0.00% | – |
| Q3 2016 | $165,000 | -22.9% | 12,319 | +14.3% | 0.00% | – |
| Q2 2016 | $214,000 | – | 10,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |